MyFinsight
Home
Blog
About
Sales Of Cortrophin
Gel
$117,126K
Sales Of ILUVIENAnd
YUTIQ
$18,718K
(-16.12%↓ Y/Y)
Total Sales Of Rare
Disease Pharmaceutical...
$135,844K
(30.67%↑ Y/Y)
Sales Of Established
Brand Royalties And...
$17,731K
Sales Of Established
Brands
$11,813K
(-10.47%↓ Y/Y)
Sales Of Generic
Pharmaceutical Products
$99,051K
(9.69%↑ Y/Y)
Sales Of Generic Other
Revenues
$1,605K
Total Sales Of Rare
Disease And Brands
$165,388K
(41.17%↑ Y/Y)
Total Sales Of
Generics And Other
$100,656K
(6.84%↑ Y/Y)
Net revenues
$266,044K
(25.87%↑ Y/Y)
Operating income
$40,460K
(191.25%↑ Y/Y)
Unrealized loss (gain) on
investment in equity...
$741K
(123.19%↑ Y/Y)
Total operating
expenses, net
$225,584K
(14.23%↑ Y/Y)
Contingent consideration
fair value...
-$622K
(-148.71%↓ Y/Y)
Income before income
tax expense
$37,097K
(252.47%↑ Y/Y)
Interest expense, net
-$3,636K
(33.14%↑ Y/Y)
Other (expense)
income, net
-$468K
(-126.91%↓ Y/Y)
Cost of sales
(excluding depreciation...
$100,158K
(34.23%↑ Y/Y)
Selling, general, and
administrative
$91,661K
(12.09%↑ Y/Y)
Depreciation and
amortization
$19,640K
(-15.64%↓ Y/Y)
Research and development
$14,747K
(-10.81%↓ Y/Y)
Net income
$24,711K
(189.05%↑ Y/Y)
Income tax expense
$12,386K
(526.82%↑ Y/Y)
Net income
available to common...
$24,711K
Back
Back
Income Statement
ANI PHARMACEUTICALS INC (ANIP)
ANI PHARMACEUTICALS INC (ANIP)
source: myfinsight.com